Eligibility

Ages Eligible for Study: 18 Years and above
Genders Eligible for Study: Male and Female

Inclusion Criteria:

• Primary tissue from patient's surgery must be EGFR-positive by certain tests.
• Patients may have up to 4 cycles of chemotherapy after surgery.
• Complete removal of the tumor by surgery.
• Able to start drug under the following timelines:
  • 6 months from the day of surgery for patients who get chemotherapy
  • 3 months from the day of surgery for those who do not get chemotherapy.
• Confirmed diagnosis of Stage IB-IIIA NSCLC.
• Patients must be accessible for follow-up visits.

Exclusion Criteria:

• History of prior radiotherapy for NSCLC either before or after surgery.
• History of heart disease or uncontrolled heart arrhythmias within the previous year.
• History of poorly controlled GI disorders that could affect the absorption of study drug.
• History of other cancer except certain skin or cervical cancers, Patients who have had other cancer are eligible if they have remained disease free for at least 5 years.
• Patients who have received chemotherapy for NSCLC before surgery.
• Tumors with mixed histology of NSCLC and SCLC. Patients with carcinoid tumors are not eligible.

View our Pre-Screening Questionnaire

email us:

medical-information@osip.com

For More Information Call: